Free Trial
TSE:FRX

Fennec Pharmaceuticals 8/13/2024 Earnings Report

Fennec Pharmaceuticals logo
C$11.38 +0.28 (+2.52%)
As of 11:01 AM Eastern

Fennec Pharmaceuticals EPS Results

Actual EPS
-C$0.27
Consensus EPS
C$0.08
Beat/Miss
Missed by -C$0.35
One Year Ago EPS
N/A

Fennec Pharmaceuticals Revenue Results

Actual Revenue
$9.94 million
Expected Revenue
$18.67 million
Beat/Miss
Missed by -$8.73 million
YoY Revenue Growth
N/A

Fennec Pharmaceuticals Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Fennec Pharmaceuticals Earnings Headlines

HC Wainwright Analysts Boost Earnings Estimates for TSE:FRX
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?
Wedbush Lifts Earnings Estimates for Fennec Pharmaceuticals
See More Fennec Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fennec Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your email.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals (TSE:FRX) operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

View Fennec Pharmaceuticals Profile

More Earnings Resources from MarketBeat